Published in J Virol on December 01, 1970
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol (1982) 1.54
New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34. J Clin Microbiol (1975) 1.37
Vero microcultures for adenovirus neutralization tests. J Clin Microbiol (1978) 1.28
Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers. J Clin Microbiol (1975) 1.25
Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test. Appl Microbiol (1971) 1.04
Comparison of immunization methods for producing reference adenovirus antisera in horses. Appl Microbiol (1972) 1.02
Three adenovirus type 8 genome types defined by restriction enzyme analysis: prototype stability in geographically separated populations. J Clin Microbiol (1986) 0.95
Physicochemical and serological characteristics of respiratory virus fluorescein-isothiocyanate conjugates for fluorescent-antibody diagnosis. J Clin Microbiol (1975) 0.94
Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber. J Virol (1997) 0.91
Serological and genetic characterisation of a unique strain of adenovirus involved in an outbreak of epidemic keratoconjunctivitis. J Clin Pathol (2004) 0.86
Antigenically intermediate human adenovirus strain associated with conjunctivitis. J Clin Microbiol (1981) 0.80
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol (1969) 4.99
A new and rapid method for isolating viruses by selective fluorocarbon deproteinization. Trans N Y Acad Sci (1956) 3.50
Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology (1967) 2.25
The structural and functional diversity of Adenovirus capsid components. J Gen Virol (1969) 2.14
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS. Proc Soc Exp Biol Med (1963) 1.72
Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes. Am J Epidemiol (1967) 1.41
Sructural proteins of adenoviruses. 3. Purification and characterization of the adenovirus type 2 penton antigen. Virology (1969) 1.34
Separation and characterization of soluble adenovirus type 9 components. J Virol (1967) 1.16
PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA. Am J Hyg (1964) 1.15
Role of adenovirus antigens in the induction of virus neutralizing antibody. J Gen Virol (1968) 1.15
The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen. Virology (1967) 1.12
The relationship between the soluble antigens and the virion of adenovirus type 3. IV. Immunological complexity of soluble components. Virology (1969) 1.10
Chromatography of adenoviruses on calcium phosphate columns. Acta Virol (1962) 1.08
Immunological relationships between hexons of certain human adenoviruses. J Virol (1969) 1.04
The structure of group II adenoviruses. J Gen Virol (1967) 1.00
[Serological relationship of group II adenoviruses]. Arch Gesamte Virusforsch (1968) 0.94
Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15. J Virol (1968) 0.93
Capsid mosaics of intermediate strains of human adenoviruses. J Virol (1969) 0.85
The serological relationship of the soluble antigens of adenovirus type 19. J Gen Virol (1968) 0.82
The proteins of adenovirus type 5. Arch Gesamte Virusforsch (1970) 0.80
Neutralization and adenoviruses by component antisera. (Brief report). Arch Gesamte Virusforsch (1969) 0.79
[Type-specific antigens of adenovirus]. Arch Gesamte Virusforsch (1969) 0.79
Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07
Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol (1969) 4.99
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol (1999) 3.35
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
Standardized viral hemagglutination and hemagglutination-inhibition tests. I. Standardization of erythrocyte suspensions. Appl Microbiol (1969) 3.19
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The epidemiology of AIDS. Public Health Rep (1983) 3.00
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Letter: Adenovirus type 19 keratoconjunctivitis. N Engl J Med (1974) 2.63
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
DNA restriction analysis of adenovirus prototypes 1 to 41. Arch Virol (1986) 2.20
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Coronaviridae: second report. Intervirology (1978) 2.05
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol (1988) 1.91
Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88
Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol (1985) 1.84
Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79
Further subgrouping of the human adenoviruses by differential hemagglutination. J Infect Dis (1973) 1.77
Airways function during mild viral respiratory illnesses. The effect of rhinovirus infection in cigarette smokers. Ann Intern Med (1974) 1.72
Mapping of base sequence heterologies between genomes from different adenovirus serotypes. Virology (1973) 1.71
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Protein composition of coronavirus OC 43. Virology (1972) 1.66
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol (1970) 1.60
WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ (1970) 1.58
Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57
Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J (1973) 1.56
Characteristics of noncultivable adenoviruses associated with diarrhea in infants: a new subgroup of human adenoviruses. J Clin Microbiol (1979) 1.56
Coronaviridae. Intervirology (1975) 1.55
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55
The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period. J Infect Dis (1983) 1.51
Swine influenza virus infections in humans. J Infect Dis (1977) 1.50
Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population. Am J Epidemiol (1971) 1.44
Properties of the Hong Kong influenza virus. Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses. Bull World Health Organ (1969) 1.41
Epidemiology of influenza in the elderly: evidence of virus recycling. Am J Epidemiol (1976) 1.40
Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis (1977) 1.39
Genital infection with Herpesvirus hominis types 1 and 2 in children. Pediatrics (1968) 1.38
Nonspecific precipitation of serum proteins by sodium lauryl sulfate in agar diffusion and immunoelectrophoresis. Appl Microbiol (1971) 1.37
New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34. J Clin Microbiol (1975) 1.37
Epidemic keratoconjunctivitis. A severe industrial outbreak due to adenovirus type 8. N Engl J Med (1973) 1.37
Laboratory-based surveillance of influenza virus in the United States during the winter of 1977--1978. II. Isolation of a mixture of A/Victoria- and A/USSR-like viruses from a single person during an epidemic in Wyoming, USA, January 1978. Am J Epidemiol (1979) 1.37
Occurrence of respiratory illness due to an atypical strain of adenovirus type 11 during a large outbreak in Spanish military recruits. Am J Epidemiol (1974) 1.35
Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. J Clin Microbiol (1986) 1.33
Antigenic variants of influenza B virus. Br Med J (1973) 1.31
Studies of stools from pseudomembranous colitis, rotaviral, and other diarrheal syndromes by frequency-pulsed electron capture gas-liquid chromatography. J Clin Microbiol (1984) 1.31
Vero microcultures for adenovirus neutralization tests. J Clin Microbiol (1978) 1.28
Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and type 19 infection. J Infect Dis (1975) 1.27
New human adenovirus (candidate adenovirus type 35) causing fatal disseminated infection in a renal transplant recipient. J Clin Microbiol (1977) 1.27
Influenza A neuraminidase antibody assay with sensitized erythrocytes. Appl Microbiol (1973) 1.26
A simple double immunodiffusion test for typing influenza viruses. Bull World Health Organ (1974) 1.26
Adenoviridae: second report. Intervirology (1982) 1.26
Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers. J Clin Microbiol (1975) 1.25
Epidemic keratoconjunctivitis caused by adenovirus type 8: epidemiologic and laboratory aspects of a large outbreak. Am J Epidemiol (1981) 1.24
Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. J Infect Dis (1979) 1.21
Purification and biophysical properties of human coronavirus 229E. Virology (1976) 1.21
Inhibition of virus release by antibodies to surface antigens of influenza viruses. J Virol (1974) 1.21
Swine-like influenza virus infection in a Wisconsin farm family. J Infect Dis (1977) 1.20
Properties of the Hong Kong influenza virus. I. General characteristics of the Hong Kong virus. Bull World Health Organ (1969) 1.19
Antibodies to Herpesvirus hominis types 1 and 2 in the rabbit. J Immunol (1969) 1.18
Quantitation of antibody to non-hemagglutinating viruses by single radial hemolysis: serological test for human coronaviruses. J Clin Microbiol (1977) 1.17
Astrovirus and adenovirus associated with diarrhea in children in day care settings. J Infect Dis (1991) 1.17
Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice. Am J Epidemiol (1969) 1.16
Antiantibody enhancement of hemagglutination inhibition by influenza anti-neuraminidase. J Immunol (1972) 1.15
Some characteristics of hemagglutination of certain strains of "IBV-like" virus. J Infect Dis (1969) 1.14
Application of the single radial diffusion test for assay of antibody to influenza type A viruses. J Clin Microbiol (1975) 1.13
Measurement of hemagglutination-inhibiting antibody to influenza virus in the 1976 influenza vaccine program: methods and test reproducibility. J Infect Dis (1977) 1.13
Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med (1975) 1.13
Influenza immunization policies and practices in Japan. J Infect Dis (1980) 1.12
Epidemic mycoplasma pneumonia. N Engl J Med (1971) 1.11
Antigenic characterization of intermediate adenovirus 14-11 strains associated with upper respiratory illness in a military camp. Infect Immun (1976) 1.11
Newborn infection with Herpesvirus hominis types 1 and 2. J Pediatr (1969) 1.10
Characterization of mycoplasma species of feline origin. Am J Vet Res (1969) 1.10
Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J Clin Microbiol (1995) 1.10
An outbreak of adenovirus type 3 disease at a private recreation center swimming pool. Am J Epidemiol (1980) 1.09
Characterization of adenovirus 15/H9 intermediate strains. Intervirology (1985) 1.09
The effect of centrifugation on the rapid detection of adenovirus in shell vials. Am J Clin Pathol (1987) 1.07
Preservation of sensitized red blood cells for serologic diagnosis of mycoplasma pneumoniae infections. Am J Clin Pathol (1968) 1.07
New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice. Infect Immun (1979) 1.05
Serosurvey for "acute hemorrhagic conjunctivitis" virus (Enterovirus 70) antibodies in the Southeastern United States, with review of the literature and some epidemiologic implications. Am J Epidemiol (1975) 1.05
Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants. J Gen Virol (1972) 1.05
Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test. Appl Microbiol (1971) 1.04
Molecular epidemiology and restriction site mapping of adenovirus type 3 genome types. J Clin Microbiol (1989) 1.04
Purification and further characterization of an "IBV-like" virus (coronavirus). Proc Soc Exp Biol Med (1970) 1.04